The arrival of Retatrutide ZPHC, at a strength of 120mg, is sparking considerable buzz within the healthcare community. This novel dual GIP and GLP-1 target medication seems to offer impressive improvements in body shedding compared to existing therapies. Early clinical data have shown marked decreases in weight , possibly marking a important era f